← Back to feedRead original →
VERIFIEDET Finance·positive
Biocon gets Health Canada nod for Yesintek autoinjector pen
AI Summary
- ·Biocon has received Health Canada approval for its Yesintek autoinjector.
- ·The autoinjector is indicated for psoriasis, psoriatic arthritis, and Crohn's disease.
- ·This approval aims to enhance Biocon's immunology product offerings in Canada.